We should treat fewer patients with elevated intraocular pressure now that we know the results of the ocular hypertension treatment study
Arch Ophthalmol
.
2004 Mar;122(3):378-9.
doi: 10.1001/archopht.122.3.378.
Author
Henry D Jampel
1
Affiliation
1
Wilmer Opthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287-9205, USA. hjampel@jhmi.edu
PMID:
15006855
DOI:
10.1001/archopht.122.3.378
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Review
MeSH terms
Antihypertensive Agents / therapeutic use*
Humans
Intraocular Pressure / drug effects*
Ocular Hypertension / drug therapy*
Substances
Antihypertensive Agents